rs112355069
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP6BS1
The NM_001382.4(DPAGT1):āc.250A>Cā(p.Lys84Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,614,048 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001382.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPAGT1 | NM_001382.4 | c.250A>C | p.Lys84Gln | missense_variant | 2/9 | ENST00000354202.9 | NP_001373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPAGT1 | ENST00000354202.9 | c.250A>C | p.Lys84Gln | missense_variant | 2/9 | 1 | NM_001382.4 | ENSP00000346142.4 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152036Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251454Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135906
GnomAD4 exome AF: 0.000123 AC: 180AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.000138 AC XY: 100AN XY: 727248
GnomAD4 genome AF: 0.000243 AC: 37AN: 152154Hom.: 1 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74392
ClinVar
Submissions by phenotype
DPAGT1-congenital disorder of glycosylation;C3553645:Congenital myasthenic syndrome 13 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 10, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2021 | The c.250A>C (p.K84Q) alteration is located in exon 2 (coding exon 2) of the DPAGT1 gene. This alteration results from a A to C substitution at nucleotide position 250, causing the lysine (K) at amino acid position 84 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at